A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy

NCT07540364 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy

Interventions

DRUG: Samelisant
DRUG: Placebo

Sponsor

Suven Life Sciences Limited